The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the findings in Stockholm and talked about them with Audio Medica.
HARVEY WHITE, Auckland City Hospital, New Zealand
REFERENCE: European Heart Journal Advanced On-Line Publication April 24th, 2007
Enoxaparin could be the new
HOWARD MAYER, Pfizer Global Research, New London CT
MARK WAINBERG, McGill University, Montreal
Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and
Post a comment